Pulmonary bleeding. Hemoptysis,Haemorrhage from other sites in respiratory passages, Haemorrhage from respiratory passages, unspecified
Conditions
Interventions
Intervention 1: Interventional group: 500 mg tranexamic acid with 20ml saline were directly injected intrabronchial. Intervention 2: Control group: 1 mg adrenaline diluted with 20ml saline were direc
Treatment - Drugs
Interventional group: 500 mg tranexamic acid with 20ml saline were directly injected intrabronchial
Control group: 1 mg adrenaline diluted with 20ml saline were directly injected intrabronchial
Sponsors
Kerman University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Inclusion criteria: Patients with pulmonary hemoptysis during brochoscopy Excusion criteria: Recent history of cerebral myocardial infarction; Recent history of cardiac arrhythmia; History of arterial embolization; History of clotting disorders; History of taking warfarin and antiplatelet medicines
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Bleeding time. Timepoint: During intervention. Method of measurement: Timer. | — |
Secondary
| Measure | Time frame |
|---|---|
| Side effects of medication. Timepoint: Three months after intervention. Method of measurement: Sign assessment.;Pulmonary hemorrhage. Timepoint: Three months after intervention. Method of measurement: Sign assessment. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactRozita Zarshenas
Kerman University of Medical Sciences
Outcome results
None listed